https://www.fda.gov.tw/tc/newsContent.aspx?cid=5085&id=109P0294&type=pmds
Ann mark this message contains true information
｜originally written by Ann
部分正確。衛福部確實有公告，認為「New U Life」公司的「SOMADERM®凝膠」產品涉嫌違規，並建議消費者勿信勿購買，但原因是「廣告涉嫌誇大不實」，而未說明是否會有後遺症。
2019年1月時，美國「廣告行業自我監管系統」的調查單位，亦認為此產品未有足夠證據證明有其聲稱的「療效」及健康益處，並指出廣告中，不應有聲明或暗示Somaderm Gel產品已獲得FDA批准的主張。
2019年1月時，美國「廣告行業自我監管系統」的調查單位，亦認為此產品未有足夠證據證明有其聲稱的「療效」及健康益處，並指出廣告中，不應有聲明或暗示Somaderm Gel產品已獲得FDA批准的主張。
References
國外網站涉嫌違規廣告產品：SOMADERM®凝膠https://www.fda.gov.tw/tc/newsContent.aspx?cid=5085&id=109P0294&type=pmds
生長賀爾蒙膠囊 不應主張其有健康益處 Hormone Gel Cannot Make Health Benefit Claims
https://bbbprograms.org/archive/hormone-gel-cannot-make-health-benefit-claims-somaderm-agrees-to-modify-discontinue-certain-claims-after-ersp-review-of-its-advertising
Hormone Gel Cannot Make Health Benefit Claims; Somaderm Agrees to Modify, Discontinue Certain Claims After ERSP Review of Its Advertising
New York, NY – Jan. 23, 2019 – New U Life, Inc., the makers of Somaderm Gel, have agreed to modify or discontinue certain health benefit claims in its online advertising of the product, following reco
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.